|
The
potentially dilutive common shares that were excluded from the calculation of diluted net loss per share because their effect would have
been antidilutive are as follows. Share amounts for the periods ended September 30, 2025 and 2024, have been adjusted retroactively for
the applicable Reverse Stock Splits.
Schedule of Dilutive Common Shares were Excluded from Calculation of Diluted
| |
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
| |
|
Three Months Ended |
|
|
Nine Months Ended |
|
| |
|
September 30, |
|
|
September 30, |
|
| |
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
| Shares subject to options to purchase common stock |
|
|
36,360 |
|
|
|
41,186 |
|
|
|
36,360 |
|
|
|
41,186 |
|
| Unvested restricted stock units |
|
|
— |
|
|
|
2,868 |
|
|
|
— |
|
|
|
2,868 |
|
| Shares subject to warrants to purchase common stock |
|
|
62,978 |
|
|
|
19,444 |
|
|
|
62,978 |
|
|
|
19,444 |
|
| Total |
|
|
99,338 |
|
|
|
63,498 |
|
|
|
99,338 |
|
|
|
63,498 |
|
|